Vertiv Delivers the Acceleration July Required; Cash Discipline Is the Next Test
Key Takeaways
- July's execution test was passed with room to spare. Organic growth of 55.0% exceeded the guided 34–36%; the $100–150M recovery of delayed sales explains only a minority of the revenue upside.
- The fourth quarter no longer requires a step change in output. The $4,413M sales midpoint is only 2.3% above Q3, while EMEA's return to organic growth broadens the operating recovery.
- Cash quality improved, but the balance sheet still carries the expansion. Inventory rose to $3.29B even as customer advances and supplier credit helped finance the ramp; the one-time orders disclosure does not restore backlog transparency.
- Rating: Maintaining Outperform. Our twelve-month target rises to $290 from $265 on a higher FY27 earnings estimate, with the valuation multiple held at 30.3x. The resulting 19.5% total-return case compensates for a credible 25.4% downside scenario.
Results vs. Consensus
| Q3 FY2026 metric | Actual | Consensus | Surprise |
|---|---|---|---|
| Net sales | $4,312.8M | ~$3,750M | +$562.8M / +15.0% |
| Adjusted diluted EPS | $2.21 | $1.82 | +$0.39 / +21.4% |
| GAAP diluted EPS | $1.95 | n/a | n/a |
| GAAP gross margin | 38.1% | n/a | n/a |
| Adjusted operating profit | $1,086.9M | n/a | n/a |
| Adjusted operating margin | 25.2% | n/a | n/a |
| Adjusted free cash flow | $652.2M | n/a | n/a |
The more consequential comparison is against Vertiv’s own July commitments. Sales exceeded the $3,750M guidance midpoint by $562.8M and its $3,850M ceiling by $462.8M. Organic growth cleared the top of the range by 19 percentage points. Adjusted EPS exceeded the $1.80 midpoint by $0.41, and adjusted operating margin exceeded 24.5% by 70 basis points. The operating improvement therefore survives either the external or the internal yardstick.
Year-over-year financial comparison
| $M except EPS and margins | Q3 2026 | Q3 2025 | Change |
|---|---|---|---|
| Net sales | 4,312.8 | 2,675.8 | +61.2% |
| Gross profit | 1,643.4 | 1,010.7 | +62.6% |
| Gross margin | 38.1% | 37.8% | +33bps |
| SG&A | 556.9 | 414.3 | +34.4% |
| GAAP operating profit | 983.8 | 516.7 | +90.4% |
| Adjusted operating profit | 1,086.9 | 595.6 | +82.5% |
| Adjusted operating margin | 25.2% | 22.3% | +290bps |
| Net income | 764.5 | 398.5 | +91.8% |
| GAAP diluted EPS | 1.95 | 1.02 | +91.2% |
| Adjusted diluted EPS | 2.21 | 1.24 | +78.2% |
| Operating cash flow | 794.0 | 482.7 | +64.5% |
| Adjusted free cash flow | 652.2 | 436.0 | +49.6% |
Sequential comparison
| $M except EPS and margins | Q3 2026 | Q2 2026 | Change |
|---|---|---|---|
| Net sales | 4,312.8 | 3,274.3 | +31.7% |
| Organic growth, YoY | 55.0% | 17.8% | +37.2 points |
| Adjusted operating profit | 1,086.9 | 738.4 | +47.2% |
| Adjusted operating margin | 25.2% | 22.6% | +260bps |
| Adjusted diluted EPS | 2.21 | 1.52 | +45.4% |
| Adjusted free cash flow | 652.2 | 925.3 | −29.5% |
| Inventory, period end | 3,288.4 | 2,522.7 | +30.4% |
| Deferred revenue, period end | 4,120.5 | 3,633.7 | +13.4% |
Revenue quality: The recovery is broader than deferred shipments. Deducting management’s $100–150M catch-up estimate leaves $4,162.8–4,212.8M, still $312.8–362.8M above the old guidance ceiling. This is a revenue sensitivity, not a recalculated organic growth rate. Acquisitions contributed $156.9M to reported growth, while the company’s organic bridge removes a $9.1M currency contribution. Organic sales growth of 55.0% is the strongest evidence that July’s miss was an execution problem rather than demand destruction.
Margin quality: Unlike July, this quarter’s leverage is predominantly below gross profit. Gross margin increased only about 33bps, while SG&A fell from 15.5% to 12.9% of sales. Adjusted operating profit increased by $491.3M on $1,637.0M of additional revenue, a 30.0% incremental margin. The sequential incremental was 33.6%. Both sit within management’s 30–35% framework, supporting the structural-leverage pillar without requiring an exceptional new pricing assumption.
EPS quality: The GAAP tax rate rose to 23.2% from 19.0%; a lower tax rate did not manufacture the beat. Net interest expense fell to $6.4M from $22.8M, and $17.4M of other non-operating income helped earnings. The $0.26 gap between adjusted and GAAP EPS comprises $0.16 amortization, $0.09 contingent consideration and $0.01 acquisition costs. Those add-backs carry no tax benefit in the company’s reconciliation. The earnout expense has reached $96.1M year to date, so acquisition accounting remains relevant even as underlying operating profit improves.
Segment Performance
| Q3 2026 ($M) | Net sales | Reported growth | Organic growth | Adj. operating profit | Adj. margin |
|---|---|---|---|---|---|
| Americas | 2,988.8 | 74.5% | 66.2% | 877.3 | 29.4% |
| Asia Pacific | 779.3 | 49.9% | 48.3% | 132.4 | 17.0% |
| EMEA | 544.7 | 22.8% | 19.3% | 152.3 | 28.0% |
| Corporate | n/a | n/a | n/a | (75.1) | n/a |
| Total | 4,312.8 | 61.2% | 55.0% | 1,086.9 | 25.2% |
Americas: the recovery also restores concentration
Americas organic growth of 66.2% clears July’s high-thirties expectation and reverses the region’s 21.1% Q2 pace. Margin rose only 10bps year over year to 29.4% despite the revenue surge: product mix and new-capacity inefficiency absorbed some of the leverage. Management expects both effects to improve with utilization and a more balanced service mix.
Assessment: The region delivered the shipments the thesis required, but its share of revenue rose to 69.3% from 63.2% in Q2, and its share of regional operating profit reached 75.5%. Geographic recovery is real; diversification of the consolidated earnings base is not yet sufficient to reduce dependence on Americas demand. We move that concentration risk from CONTAINED to EMERGING.
Asia Pacific: capacity turns into profit
Organic growth accelerated to 48.3% from 25.7%, with no acquisition contribution in the regional organic bridge. Margin expanded 380bps to 17.0%. Johor is operational, and management expects improving factory utilization to support the fourth quarter. Australia and India were identified as particularly strong markets; China was described more cautiously as showing early improvement.
Assessment: APAC is now a meaningful second source of incremental earnings, contributing $63.9M of the year-over-year regional profit increase. Its margin remains well below the other regions, giving utilization gains room to contribute without assuming Americas-level profitability.
EMEA: the promised inflection has arrived
Organic growth of 19.3% compares with a 2.4% decline in Q2 and meets July’s mid-to-high-teens commitment. Adjusted operating margin reached 28.0%, up 920bps year over year and 230bps sequentially. The year-to-date organic decline is still 3.3%, which shows how much of the recovery is concentrated in the latest quarter.
Assessment: This clears the earlier EMEA downgrade condition: the region is growing organically while the full-year outlook rises. We do not extrapolate the full 920bps expansion: a single quarter at 28.0% does not establish a sustainable regional margin. The better investment evidence is that a positive revenue contribution now accompanies the margin recovery.
Key KPIs
| Indicator | Q3 evidence | Investment implication |
|---|---|---|
| Organic orders growth | More than 100% YoY | Demand signal, not a backlog dollar value |
| Services & spares sales | $719.0M; +41.5% reported; +18.1% organic | Organic pace improves from Q2’s 10.1% |
| Products offering sales | $3,593.8M; +63.6% organic | Hardware leads the growth mix |
| Deferred revenue | $4,120.5M | Customer financing remains significant |
| Inventory | $3,288.4M | Execution protection consumes capital |
| Net leverage | −0.2x | Capacity and acquisition flexibility |
Services and spares contributed 16.7% of offering revenue, down from 20.4% in Q2. Acquisitions supplied $118.3M of the $210.8M year-over-year increase. The organic improvement strengthens the installed-base argument, but purchased capability still accounts for more than half the reported increase. Offering-level services and spares includes a different product classification from the income statement’s services line of $675.7M.
Key Topics & Management Commentary
Overall Management Tone: July’s confident but poorly quantified defense became a more evidential account of execution, including a dollar range for recovered revenue. Management remained selective on disclosure and guarded on product quality, despite the stronger operating result.
1. Catch-up is a minority of the acceleration
The central July concern was whether multi-factory projects could be completed at the required pace. Management now identifies $100–150M of delayed revenue in Q3. The remaining beat is large enough that the quarter cannot reasonably be dismissed as a timing reversal.
So we had that delay in second quarter revenue recognition. Came in third quarter, so brought third quarter up a little bit more than would have historically been there. So if you adjust for that, the $100 million to $150 million, you are more in a sequential nature that we have seen in the past from the third quarter to fourth quarter number if you look at that per the guide.
— Craig Chamberlin, CFO
Assessment: The second-half acceleration risk moves from MATERIALIZING to CONTAINED. Recovery of delayed revenue was a condition of July’s Outperform, and that condition was fulfilled; the new Q4 burden is much smaller sequentially.
2. Orders answer the demand question, selectively
The order disclosure is a useful challenge to the fear that customer appetite had weakened. It is not equivalent to reinstating an orders series or meeting July’s $15B backlog signpost.
By the way, to be clear, we are not planning to share orders data going forward.
— David Cote, Executive Chairman
Assessment: We retain EMERGING on disclosure risk. One strong growth comparison improves the demand assessment, but it cannot reveal cancellations, customer mix in dollars or the amount of executable backlog.
3. Converged systems turn customer labor scarcity into an opportunity
OneCore and SmartRun bring work into factories and reduce dependence on scarce construction labor. Management described design time reduced by a factor of ten and deployment time cut by up to half, with a Norway reference project. Those are customer-value claims, not measured Vertiv margin uplift.
This cuts deployment time by up to half. The result is up to 30% more cumulative AI token output in the first 12 months from project kickoff. Same installed capacity, just productive much sooner for our customers.
— Giordano Albertazzi, CEO
Assessment: The opportunity to win more project scope remains compelling. We keep the convergence pillar AT RISK because company-wide margin expansion does not isolate system profitability, and faster revenue delivery still requires additional inventory and process maturity.
4. Capacity expansion now has demonstrated throughput
The 31.7% sequential sales increase is evidence that investment is producing output. Management highlighted expansions across all three regions, supplier capacity agreements and the operational Johor factory. Full-year capex remains about 4% of revenue, now approximately $586M on the raised sales midpoint.
These capacity additions are already contributing to our Q3 and Q4 growth. And it is not just our own capacity. We keep on proactively securing and expanding long term capacity agreements with key suppliers to ensure their scale in lockstep with our growth.
— Giordano Albertazzi, CEO
Assessment: Capacity is no longer merely a promise supporting a residual forecast. The new manufacturing leadership and continuing process work nevertheless argue for retaining EMERGING on project-scale execution risk rather than declaring the learning curve complete.
5. Cash generation improves while inventory keeps rising
Q3 operating cash flow of $794.0M exceeded the $490.2M source from deferred revenue, unlike Q2. Subtracting that source leaves $303.8M of operating cash flow. However, inventory and receivables consumed $1,398.8M combined, largely financed by $723.7M of payables growth and customer advances.
The improvement was driven by higher adjusted operating profit. Partially offset by working capital usage and higher net CapEx.
— Craig Chamberlin, CFO
Assessment: Cash quality improved, but the prior commitment to inventory conversion is not yet delivered: the balance rose another $765.7M. We expect positive cash generation to persist, while treating further supplier-credit and customer-advance dependence as a constraint on valuation.
6. Power architecture remains a staged revenue opportunity
The call preserves the staged 800-volt roadmap: initial rack-level revenue during 2027 and native architecture deployment in 2028, after validation. That supports the content-per-megawatt pillar without moving the full data-hall opportunity into next year’s estimates.
When it comes to the way we think about product launches today, we cannot think in terms of product launches separate from having the right capacity. Dedicated production line, dedicated supply chains with that.
— Giordano Albertazzi, CEO
Assessment: The technology timeline is consistent with July. Our 2027 sales increase rests on current capacity and customer programs, with no separate speculative premium for a full native 800-volt rollout before its stated deployment window.
7. Pricing and productivity must fund continued investment
Management still expects price-cost to be positive for 2026, including current tariffs. For 2027 it offered directional growth and margin expansion, while declining numerical guidance.
Despite an ongoing inflationary environment, we expect continued margin expansion powered by productivity, strong commercial execution, operational rigor, and increasingly deep vertical operating system adoption.
— Giordano Albertazzi, CEO
Assessment: We raise FY27 adjusted margin to 26.0% from 25.0%. That is a modest step above the Q4 midpoint of 25.8%, supported by utilization and continued leverage, rather than an assumption that all incremental demand drops straight to profit.
8. Capital allocation favors capability over a buyback signal
Liquidity reached $6.2B, but the call did not announce the repurchase authorization sought in July. The UtilityInnovation Group acquisition extends the discussion toward microgrid and power architecture, potentially bringing Vertiv into customer projects earlier.
We will continuously look at things like, you know, buybacks, dividends, and stuff like that, but in terms of where we see the most value accretive nature is investing in our own capabilities and capacity and or inorganic plays.
— Craig Chamberlin, CFO
Assessment: The buyback signpost remains unmet. Given the demonstrated return from added throughput, reinvestment is defensible; we no longer treat absence of an authorization alone as evidence of weak confidence. We assume no repurchase benefit in FY27 EPS and continue to monitor acquisition returns and earnout adjustments.
Guidance Update
| FY26 metric | July midpoint | October range / midpoint | Change in midpoint |
|---|---|---|---|
| Net sales | $14,000M | $14,450–14,850M / $14,650M | +$650M |
| Organic growth | 31% | 37–39% / 38% | +7 points |
| Adjusted operating profit | $3,325M | $3,475–3,555M / $3,515M | +$190M |
| Adjusted operating margin | 23.8% | 23.5–24.5% / 24.0% | +20bps |
| Adjusted diluted EPS | $6.70 | $7.10–7.20 / $7.15 | +$0.45 |
| Adjusted FCF | $2,500M | $2,600–2,800M / $2,700M | +$200M |
Q4 guidance is $4,313–4,513M of revenue, 49–51% organic growth, 25.3–26.3% adjusted margin and $2.22–2.28 adjusted EPS. The revenue midpoint is above roughly $4.31B of consensus, and EPS is above the $2.20–2.21 consensus range. Full-year EPS guidance exceeds the pre-release $6.71–6.73 consensus range.
Most of the annual raise has already been earned. Against the old Q3 midpoint, sales beat by $562.8M; the $650M annual increase adds only about $87M beyond that beat. Similarly, the $0.45 annual EPS raise follows a $0.41 Q3 beat against guidance. This is a strong quarter with modest additional uplift to the year’s remaining assumptions, not an equally large upgrade to Q4.
The Q4 sales midpoint is only 2.3% above the quarter just delivered. Adjusting Q3 for the catch-up range makes that sequential requirement about 4.8–6.0%, still far less demanding than the July bridge. Nine-month adjusted FCF of $2,230.3M leaves $469.7M for Q4 at the full-year midpoint. Implied second-half FCF is $1,121.9M, about 50.4% of second-half adjusted operating profit, better than July’s roughly 45% assumption but still consistent with working-capital absorption.
Analyst Q&A Highlights
Does the fourth-quarter guide conceal a slowdown?
Q: Usually, you see a pretty nice step up in revenue, Q3 to Q4. The guidance implies sort of more sequentially flat, obviously, Q3 was much better. So maybe you can just address that.
— Amit Mehrotra, UBS
A: And, as you and I have said, as we have walked through these things, you know, there is always some prudence in the way that we look at our-- so our fourth quarter guide would be assessing for that as well. In terms of kinda where does it sit as going into to 2027, we feel good about where we are right now and exiting the year. We will not comment on 2027 of where it is going to go Just to point back to the fact of pipelines look good. As Gio mentioned, the order book looks good. Feel confident about our ability to execute given the third quarter and what we have in front of us here in fourth quarter.
— Craig Chamberlin, CFO
Assessment: The CFO paired the catch-up explanation discussed above with explicit prudence in the guide. That supports a manageable Q4 bridge, but not extrapolation of 50% organic growth through 2027. Our FY27 growth assumption is materially lower.
Are product-quality concerns resolved?
Q: there is been chatter of compressors that have been burning out and heat levels and UPS machines or UPS systems that are overheating and would you. I mean, could you give us a little bit of color?
— Scott Davis, Melius Research
A: When it comes to new products, it is true that if the new product mix is higher, then there is a kind of a higher let's say, statistically distributed, curve in the initial phase of new product. So there might be a mix there. But when we look at the way the infant phase of a new product quality evolves, how it evolves we see improvements, constant improvements. So we feel good about that. And it is it is a complicated industry. It is a complicated, set of products and that is true across the entire industry. it is not a it is not a Vertiv thing. So I feel pretty good at where we are. We are not perfect. Absolutely. We are not perfect. But we believe that we continue to reinforce and focus on, quality and reliability as 1 of the competitive advantages for us.
— Giordano Albertazzi, CEO
Assessment: Management described improving early-life product performance but provided no failure-rate or warranty data. The question is an allegation, not an established defect finding. Strong shipments and orders challenge a broad customer-rejection thesis; they do not settle reliability across the installed base.
Do service economics improve with system scope?
Q: Can you share some KPIs and, getting quite a few questions about any difference in attachment rates on electrical and thermal, and how should we think about the opportunity there going forward?
— Andrew Obin, Bank of America
A: We will not go into details of attach rates, but let's talk, directionally. We are pleased by the direction in which our attach rates, are evolving. that is a metric that we obsessively and obsessively and very granularly measure regionally product line, everything.
— Giordano Albertazzi, CEO
Assessment: The answer supports direction but supplies no rate. The independently disclosed 18.1% organic services-and-spares growth is the usable signpost; it improves the case without establishing the recurring earnings mix that would justify a higher multiple.
Are power and permitting constraints delaying shipments?
Q: Are you seeing any evidence of data center construction projects pushing to the right because of these pacing items?
— Nicole DeBlase, Deutsche Bank
A: What we see in terms of movements at project level is nothing out of the ordinary from what we have seen in the industry over the years. So it is a construction. Activity. So sometimes there are slippages. There are complexities on-site. Some of the complexity, of course, we are addressing changing the name of the game with, with our converged infrastructure. But we do not see those dynamics translating into the meaningful or, let's say, material out of the ordinary shifts
— Giordano Albertazzi, CEO
Assessment: The answer rejects unusual current slippage, not the existence of construction risk. Factory integration can remove site labor constraints, while interconnect and permitting still govern customer timing. Those constraints remain part of our downside case.
Is order growth merely longer-dated booking?
Q: Are they just placing orders further down the timeline? And is that having any impact on the backlog? Because in the past, you have said 12 to 18 months. Is that still the range? Has it shifted around a little bit?
— Varun Govindaraj, Bernstein
A: The dynamics of orders in terms of, how far out orders are placed, that is not changed dramatically. I would say not changed a lot quarter to quarter or in the last few quarters. We are talking about that 12 to 18 months and can very be very, very much true right now. And it is. that is certainly 1 of the aspects that we analyze a lot. Clearly, as you will very well remember, we are very strict in what we call a backlog. We do not call a capacity agreement a backlog. We only call backlog what is a squarely a purchase order.
— Giordano Albertazzi, CEO
Assessment: This is useful support for order quality: management says the horizon has not materially stretched and capacity agreements are excluded. It reduces one possible explanation for the growth rate, while leaving the absolute backlog and cancellation protections undisclosed.
How much margin expansion is realistic in 2027?
Q: Just wondering on as we look into 2027, anything you would like to set us up with in terms of margins? And I say that because, you know, we have some noise in the back half of this year, but it seems like the setup with incremental volume and better mix and capacity going away Should set you up for, I think, what should be a really strong starting point. Do we see-- do we see these kinda exit margins as the starting point for next year?
— Andrew Buscaglia, BNP Paribas
A: No. I mean, we will not specifically talk about 2027 in terms of where we sit on incrementals I say, historically, what we have said and kinda go forward with what we laid out in the long term planning is we aim to be at the 30% to 35%. A lot of things can influence that, especially when you are going through growth. And if you go through growth, you tend to see a little bit lower of that. If you are more of a steady state, see a little bit of a higher of that based on where your volume is. I would say that is still the right framework to look at it through.
— Craig Chamberlin, CFO
Assessment: The response gives an incremental-profit framework, not a promised exit-margin floor. Our 26.0% FY27 margin produces a 33.6% incremental against the new FY26 guide, within that range; expansion would be harder if growth required another costly capacity surge.
What They're NOT Saying
- No absolute backlog or regular orders commitment. The isolated order-growth disclosure does not meet July’s backlog-dollar signpost. A stable reporting series would allow investors to test conversion rather than infer it.
- No quantified quality or system-margin data. Better throughput does not establish warranty trends or whether converged infrastructure is accretive. These are distinct reasons to retain execution and convergence caution.
- No numeric 2027 guidance or service attach rate. Management’s direction supports an earnings increase, but the scale remains an analyst assumption until the next results call.
- No buyback authorization in the release or call. Capital is being retained for capacity and acquisitions; the absence leaves dilution and acquisition returns central to per-share value.
Market Reaction
VRT closed at $242.94 on October 28, up 16.5% from $208.56. It opened at $243.00, traded between $228.81 and $245.31, and recorded 19.5M shares of volume, 3.6 times its 30-day average. The S&P 500 gained 0.3%. Entering the print, Vertiv was up 28.7% year to date but down 14.5% over the preceding 30 days.
The result gives investors a concrete reason to revisit the execution discount: the July shortfall recovered, output expanded beyond that recovery, and an unusually strong orders disclosure challenged fears of fading demand. The pre-print decline also made the stock sensitive to evidence that the operating story remained intact. Those are plausible explanations for the rally, not a measured attribution of each percentage point.
At the close, Vertiv trades at 34.0x the new FY26 adjusted EPS midpoint and 25.3x our FY27 estimate. The rally therefore leaves the current-year multiple near July’s 33.3x, but with a substantially stronger exit run rate. That combination matters more than whether the stock recovered all of the prior decline.
Street Perspective
Execution recovery or a timing-assisted peak?
Bull view: The shipment surge, stronger orders and raised outlook restore confidence that capacity can be monetized. Bear view: Catch-up and an exceptional quarter can disguise continued difficulty delivering projects consistently. Our take: The normalized sales sensitivity still clears the old ceiling. The bull case wins this quarter’s test, while inventory growth argues against declaring execution permanently solved.
Does more than 100% orders growth justify a new valuation tier?
Bull view: Order momentum and broad regional demand support a longer earnings runway than the recent selloff implied. Bear view: Selective disclosure and AI funding concerns limit visibility beyond near-term deliveries. Our take: We raise earnings rather than the multiple. The orders figure is meaningful, but one comparison is insufficient to price a structurally more predictable revenue stream.
Our Estimates & Valuation Framework
| Assumption | July case | Revised case | Basis |
|---|---|---|---|
| FY26 sales | $14.00B | $14.65B | New guidance midpoint |
| FY26 adjusted EPS | $6.70 | $7.15 | New guidance midpoint |
| FY26 adjusted FCF | $2.50B | $2.70B | New guidance midpoint |
| FY27 sales | $17.50B | $18.50B | 26.3% growth; 4.8% above Q4 midpoint annualized |
| FY27 adjusted operating margin | 25.0% | 26.0% | 33.6% incremental profit on FY26 guide |
| FY27 adjusted operating profit | $4,375M | $4,810M | Sales multiplied by margin |
| FY27 net interest expense | $40M | $40M | Conservative expense despite net cash |
| FY27 effective tax assumption | 22% | 22% | Normalized rate; no discrete benefit assumed |
| FY27 diluted shares | 395M | 395M | No repurchase assumption |
| FY27 adjusted EPS | ~$8.75 | ~$9.59 | Explicit bridge below |
| Base multiple | 30.3x | 30.3x | Unchanged execution/disclosure discount |
We estimate FY27 GAAP operating profit of $4,510M after $300M of assumed amortization and acquisition-related charges, versus $4,810M adjusted. Subtracting $40M net interest and applying 22% tax produces $3,486.6M of GAAP net income. Adding back $300M yields $3,786.6M of adjusted net income, or $9.59 on 395M diluted shares. The $300M charge assumption is modestly above FY26 guided amortization of $280.5M; we assume no additional earnout revaluation or discrete tax adjustment. Our calculation subtracts operating charges before tax and adds them back once after tax.
This bridge deserves explicit caution: Vertiv’s published EPS adjustment convention does not tax-effect its operating add-backs, and the mix of future tax and acquisition adjustments is uncertain. A simpler normalized calculation that taxes adjusted pretax profit at 22% yields $9.42. We value the more conservative $9.42 sensitivity at the same 30.3x to obtain about $285, still above the reaction close. The $290 base target uses our $9.59 estimate, rounded from $290.58; the target increase from $265 is driven by earnings, with no multiple expansion.
| 12-month scenario | FY27 operating assumptions | EPS / multiple | Target | Total return from $242.94 |
|---|---|---|---|---|
| Bull | $20.0B sales; 27% adjusted margin; $40M interest; 22% tax; 395M shares | $10.58 normalized / 34x | $360 | +48.3% |
| Base | $18.5B sales; 26% adjusted margin; bridge above | $9.59 / 30.3x | $290 | +19.5% |
| Bear | $16.0B sales; 23% adjusted margin; $100M interest; 23% tax; 395M shares | $6.98 normalized / 26x | $181 | −25.4% |
Returns include an assumed $0.25 of dividends over twelve months, approximately the recent quarterly cash payout annualized, with no dividend growth. The bull and bear cases use normalized after-tax adjusted operating earnings without separate reconciliation benefits. The bear case assumes growth slows to 9.2%, utilization and pricing fail to sustain the guided margin, and financing or construction constraints delay customer projects. Net cash reduces financial distress risk; it does not protect the valuation from lower earnings.
We retain 30.3x because the growth and margin outlook merits a premium, while project cyclicality, disclosure limits and customer financing risk constrain what we will pay. Our 19.5% base total return exceeds an assumed 8–10% twelve-month S&P 500 return hurdle, with the bull case offering additional upside. The 25.4% bear downside is material; Outperform reflects the stronger evidence for the base case, not a claim that the downside has disappeared.
Thesis Scorecard Post-Earnings
| Standing thesis point | Status change | Quarter’s evidence |
|---|---|---|
| Bull 1: Content per megawatt rises with density | ON TRACK (unchanged) | 800-volt roadmap remains staged through 2027 validation/revenue and 2028 native deployment; no early full-rollout assumption. |
| Bull 2: Operating leverage is structural, not cyclical | ON TRACK (unchanged) | 30.0% YoY incremental margin and 33.6% sequential incremental support the framework despite growth investment. |
| Bull 3: Convergence concentrates the addressable spend | AT RISK (unchanged) | Customer deployment benefit and recovered shipments support scope capture; system-level margin accretion remains unmeasured. |
| Bear 1: The second-half acceleration is asserted, not evidenced | MATERIALIZING → CONTAINED | 55% organic growth clears the 34–36% test; Q4 midpoint needs only 2.3% sequential sales growth. |
| Bear 2: Valuation leaves no room | CONTAINED (unchanged) | 34.0x FY26 guide and 25.3x our FY27 EPS leave a 19.5% base total-return case, with a substantial downside scenario. |
| Bear 3: Disclosure of the key leading indicator has regressed | EMERGING (unchanged) | Orders growth and catch-up dollars improve disclosure; no backlog dollars or commitment to regular orders reporting. |
| Bear 4: Americas hyperscale concentration is the consolidated result | CONTAINED → EMERGING | Americas reaches 69.3% of revenue and 75.5% of regional profit despite international recovery. |
| Bear 5: Execution at project scale is a constraint distinct from capacity | EMERGING (unchanged) | Revenue recovered, but inventory is still growing and quality/process maturity remains a live test. |
Overall: The thesis strengthens because its most immediate downside trigger was disproved by delivered results. The technology and operating-leverage pillars remain on track; the convergence economics and project execution risks remain unresolved. Increased Americas concentration offsets part of the improvement in geographic growth.
Action: Maintain Outperform with a $290 twelve-month target. The next tests are Q4 delivery within the $4,313–4,513M sales and $2.22–2.28 EPS ranges, chiller capacity doubling by year-end, and inventory/cash conversion against the $2.7B annual FCF midpoint. We would reassess the rating if execution again misses the company’s own range while inventory continues to outgrow sales, or if 2027 guidance fails to support our 26.0% margin trajectory. Repeatable delivery and evidence of system-level profitability would support the bull case; one exceptional orders comparison does not meet that standard by itself.